The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

The Cognitive Neuroscience of Memory Function and Dysfunction in Schizophrenia

(2008) Charan Ranganath et al.   BIOLOGICAL PSYCHIATRY

The Cognitive Neuroscience of Working Memory: Relevance to CNTRICS and Schizophrenia

(2008) Deanna M. Barch et al.   BIOLOGICAL PSYCHIATRY

Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology

(2008) David J. Potter et al.   JOURNAL OF FORENSIC SCIENCES

Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

(2008) Deepak Cyril D'Souza et al.   NEUROPSYCHOPHARMACOLOGY

Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity

(2008) W. Shen et al.   SCIENCE

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour

(2007) T. Rubino et al.   NEUROPHARMACOLOGY

Cannabinoid pharmacology: the first 66 years

(2006) Roger G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY